… management of patients with acute myeloid leukemia (AML). These chromosomal abnormalities
have been used to categorize patients into 3 risk groups: favorable, intermediate, and …

… -risk, and 53% of intermediate-risk AML patients per ELN … therapy choices in intermediate-risk
AML patients. For instance… were used for risk classification, intermediate-risk patients were …

… Univariable survival analysis (Table 2) indicated inferior OS in intermediate-risk AML patients
with FLT3 ITD mutations (hazard ratio [HR] = 1.41; P = .017), whereas CEBPA DM (OS: HR …

… factor in patients with intermediate-risk cytogenetics, and its … separate AML patients with
intermediate-risk cytogenetics into … prognosis in AML patients with intermediate-risk cytogenetics, …

… 549 younger patients (aged 14-60 years) with intermediate-risk acute myeloid leukemia,
154 … postremission treatment for patients with intermediate-risk acute myeloid leukemia. …

… confined to the 96 patients at intermediate risk according to the European Leukemia Network
classification. Most importantly, all 41 patients relapsing after consolidation chemotherapy (…

… For those with intermediate-risk cytogenetics, studies showed that auto-HSCT may …
stratification to the patients [45, 46]. In our study, five patients with intermediate molecular genotypes …

… Acute myeloid leukemia with intermediate risk (cytogenetic and molecular; int-risk AML) …
The results of this trial will help answer the question of whether patients with int-risk AML …

… in 223 patients under the age of 60 years old with intermediate-risk AML in CR1. Patients …
) obtained improved overall survival (OS) than patients who treated with chemotherapy (5-year …

… intermediate cytogenetics. Because prognosis varies most widely among patients with
intermediate … The non-diploid intermediate group included patients with chromosomal aberrations …